Clinical Trial Update: Hyperapo B and Coronary Heart Disease

View source ↗

Summary

Clinical trial update on Hyperapo B evaluating its effect on coronary heart disease; the NHLBI-sponsored study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Coronary Artery Disease
• Diabetes Mellitus
• Familial Hypercholesterolemia
• Obesity

Drugs mentioned

• Hyperapo B

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Status: COMPLETED